(2E)-1-(2,5-dichlorophenyl)-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4,4',4'',4'''-(PYRENE-1,3,6,8-TETRAYL)TETRABENZOIC ACID, 97%, 5g

3,3-Bis(4-hydroxy-2,5-dimethylphenyl)isobenzofuran-1(3H)-one, 95.0%, 100g

2-Bromo-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one, 98%, 10g

6-bromo-1H,2H,3H-pyrrolo[3,2-b]pyridine, 95.0%, 1g

4-Chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, 95.0%, 5g

2-Bromo-4-chloropyrimidine, 100mg

Pasteur pipettes with scale Filling volume 1.8 ml, 2 ml, Non sterile, 1 x 500, 152 mm, 500 pieces

4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline, 95.0%, 100g

4-(4-(Trifluoromethyl)benzyl)piperidine, 95.0%, 5g

1-(4-Aminophenyl)-1H-pyrrole-2,5-dione, 93%, 1g

(4s)-4-Isopropyl-5,5-diphenyl-3-[(2r,3s)-4,4,4-trifluoro-3-hydroxy-2,3-dimethyl-butanoyl]oxazolidin-2-one, 98%, 5g

Incubation shaker SI-200D, 1 piece